Filter your results
- 4
- 4
- 4
- 1
- 1
- 1
- 1
- 4
- 4
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironmentJournal of Hepatology, 2023, 78 (2), pp.343-355. ⟨10.1016/j.jhep.2022.10.011⟩
Journal articles
hal-04017104v1
|
||
|
Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative DiseaseViruses, 2022, 14 (5), pp.1070. ⟨10.3390/v14051070⟩
Journal articles
hal-04013137v1
|
||
|
A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factorNature Communications, 2020, 11 (1), pp.2707. ⟨10.1038/s41467-020-16517-w⟩
Journal articles
inserm-02879963v1
|
||
|
HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic ResponseGastroenterology, 2019, 156 (8), pp.2313-2329.e7. ⟨10.1053/j.gastro.2019.02.038⟩
Journal articles
inserm-02312806v1
|